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ABSTRACT 
 Candida albicans is an opportunistic yeast that causes diseases such as yeast infections, oral 
thrush, and systemic blood infections. The host-pathogen interactions between C. albicans and host 
immune cells such as macrophages are complex and dynamic, with pattern-recognition receptors 
(PRRs) such as Dectin-1 and the mannose receptor playing a key role in yeast phagocytosis via 
recognition of structures on the cell surface. Previous studies have yielded conflicting results about 
the relative importance of these and other PRRs, making further research necessary. Once 
internalized by macrophages, C. albicans is often able to survive phagocytosis by employing virulence 
factors such as secreted aspartyl proteases (SAPs). The goal of this project was to further elucidate 
the roles of host PRRs and yeast SAPs by using an in vitro macrophage invasion assay to quantify C. 
albicans survival following exposure to murine macrophages. The results indicate that murine 
macrophages lacking either the mannose receptor or Dectin-1 are impaired in their ability to 
eliminate C. albicans. However, simultaneous knockout of both receptors led to an enhanced ability 
to eliminate C. albicans, likely pointing to involvement of additional receptors, a phenomenon that 
merits further study. Single gene deletion of SAPs 1-6 in C. albicans was shown to cause decreased 
survival and may provide evidence for the potential use of SAPs as a target for novel antifungal 
therapy. 
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INTRODUCTION 
Emerging fungal diseases 
 Opportunistic fungal infections have grown in frequency in recent years. These infections 
are caused by agents including common fungi such as Candida albicans, Cryptococcus neoformans, and 
Aspergillus fumigatus as well as rare and emerging pathogens. While many of these fungi are members 
of a healthy microbiome, any fungus has the potential to become invasive and cause a lethal 
infection if the individual is sufficiently immunocompromised. Populations at risk for these types of 
infection include organ transplant recipients, individuals with AIDS, patients undergoing 
immunosuppressive therapy, the elderly, and children born prematurely, among others (Pfaller & 
Diekema, 2004). 
C. auris is one intriguing example of an emerging fungal pathogen of the Candida genus. C. 
auris was first identified in 2009, the causative agent of an ear infection of a patient in Japan. Since 
then, it has been associated with life-threatening, primarily nosocomial, infections at the 
international level, with outbreaks in regions such as Asia and South America. Like C. albicans, C. 
auris forms biofilms. However, one distinguishing feature of C. auris is its well documented high 
resistance to antifungals, including reduced susceptibility to azoles and amphotericin B (Sherry et al., 
2016). A study by Chowdhary et al. (2014) examined the drug susceptibility of C. auris using 15 
clinical isolates from north India, Japan, and Korea. Of these 15, all were resistant to fluconazole, 
73% were resistant to voriconazole, 47% were resistant to flucytosine, and 40% had high minimum 
inhibitory concentrations (MICs) of caspofungin. Not surprisingly, this same study observed 
breakthrough fungemia in 29% of patients and failure of antifungal therapies in 67% of these. While 
it should be noted that individuals with healthy immune systems are at low risk for C. auris 
infections, the high resistance is poses a serious concern for immunocompromised patients (Sherry 
et al., 2016). Additionally, C. auris has been isolated from a number of tissue types and bodily fluids, 
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including pus and broncheoalveolar lavage (BAL) fluid (Chowdhary et al., 2014). This indicates that, 
while first discovered in an ear infection, C. auris may have the potential to cause various diseases. 
 Members of the Candida genus are some of the most common fungal pathogens. Over 17 
Candida species have been shown to cause bloodstream infections. However, just four species cause 
around 95% of these infections: C. albicans, C. glabrata, C. parapsilosis, and C. tropicalis (Pfaller & 
Diekema, 2004). In this study, I will focus on C. albicans. Other opportunistic fungi include 
Trichosporon spp., Rhodotorula spp., and Geotrichum capitatum, and less common but increasingly drug-
resistant species such as Aspergillus terreus (Pfaller & Diekema, 2004). The landscape of fungal 
infections is changing, as new species such as C. auris emerge and well-characterized species such as 
C. albicans develop drug resistance. Because of this, it is vital to continue to study these organisms in 
order to understand how they cause a disease state and how infections can best be treated. 
 
Candida albicans as a human pathogen 
 Candida albicans is an opportunistic dimorphic fungus that causes disease in humans. A 
member of the healthy microbiota, C. albicans lives commensally in most humans, asymptomatically 
colonizing the reproductive tract, oral cavity, gastrointestinal tract, and skin. Other members of the 
host microbiota keep it in check and help prevent infection. However, this balance can be disrupted 
by changes in environmental pH, immunosuppressant therapy, or alterations to the microbiome 
ecology often caused, for example, by antibiotics. Frequently, these opportunistic infections are 
superficial mucosal and dermal infections, including vaginal yeast infections, thrush, and diaper rash 
(Nobile & Johnson, 2015). Three quarters of healthy women experience at least one vaginal yeast 
infection over the course of their lives and 5% suffer recurrent infections (Naglik, Challacombe, & 
Hube, 2003). 
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 In addition to these superficial infections, Candida infections have the potential to be life-
threatening, especially when the pathogen enters the bloodstream. Sepsis infections have significant 
mortality rates and species in the CTG clade including closely related species but primarily C. albicans 
cause 15% of hospital-acquired sepsis infections (Nobile & Johnson, 2015). Overall, C. albicans is the 
fourth leading cause of nosocomial infections, and the incidence of such infections has increased 
greatly over the past 20-30 years (Naglik et al., 2003). 
 One property of C. albicans that makes it an especially effective pathogen is its ability to 
reversibly switch between two morphologies: yeast and hyphal. Strains permanently locked into 
either morphology have been shown to be avirulent (Gantner, Simmons, & Underhill, 2005). A 
study by Saville, Lazzell, Monteagudo, and Lopez-Ribot (2003) demonstrated that the yeast form is 
necessary for systematic dispersal, while the hyphal form is required for pathogenicity via infiltration 
of host cells. Additionally, C. albicans acts as an effective pathogen through the formation of 
biofilms, which are comprised of multiple cell types (both yeast and hyphal as well as an 
intermediate pseudohyphal form) encased in a highly structured extracellular matrix (ECM). This 
poses a particular danger in medical devices, such as catheters and dentures, as biofilm accumulation 
on implanted devices can lead to easy access to the bloodstream for the pathogen (Nett, Sanchez, 
Cain, Ross, & Andes, 2011). While there are a number of antifungal medications currently available 
to treat these infections, systemic C. albicans infections are fatal 42% of the time even with proper 
treatment (Wisplinghoff et al., 2003). 
  
Antifungals and antifungal resistance 
 The three most common classes of antifungals are azoles, polyenes, and echinocandins. All 
target components of the cell wall. Azoles and polyenes both work by targeting ergosterol, a sterol in 
the fungal cell membrane (Ford et al., 2015). Azoles such as fluconazole inhibit the enzyme 
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lanosterol 14-α-sterol demethylase, which converts lanosterol to ergosterol, resulting in a reduced 
ergosterol content. By reducing ergosterol content, these drugs alter the structure and function of 
the cell membrane in such a way that fungal growth is suppressed (Sanguinetti, Postarero, & Lass-
Flörl, 2015). Polyenes, which include Amphotericin B, exhibit high toxicity and are therefore used 
sparingly. By contrast, azoles have relatively few side effects and is easily bioavailable orally, making 
them more widely used (Ford et al., 2015). Echinocandins like casponfungin are fungicidal, and act 
by inhibiting β(1,3)D-glucan synthase. This leads to a deformed cell wall, which results in cell death. 
The Infectious Diseases Society of America (ISDA) and the European Society of Clinical 
Microbiology and Infectious Diseases (ESCMID) generally recommend echinocandins as the first 
line of treatment, with ISDA suggesting the use of azoles for patients with mild infections and who 
have not had prior azole exposure (Sanguinetti et al., 2015) 
 Many commonly used antifungals such as fluconazole are fungistatic, meaning they do not 
kill the fungus, but merely stops it from growing. The downside to this is that it gives the fungus 
time to potentially develop drug resistance (Ford et al., 2015). There are a number of ways fungi 
such as C. albicans can exhibit drug resistance. Some strains do have a natural resistance, but it is also 
common for strains that are initially susceptible to develop resistance. Resistance to fluconazole in 
C. albicans is rare at approximately 1.4%. Mechanisms of azole resistance include induction of multi-
drug efflux pumps, upregulation of the target enzyme, and the development of bypass pathways. 
Resistance to echinocandins may come about by mutations in the target enzyme and initiation of 
adaptive stress response. Specifically, Candida species have been shown to increase chitin content in 
the cell wall in order to overcome the lack of β-glucans, as evidenced by strains that grow at supra-
MIC concentrations of caspofungin and have significantly higher chitin content. Cross-resistance 
has been well documented between different azoles, and while cross-resistance among azoles and 
echinocandins is less common, there have been reports of multi-drug resistant C. glabrata. Polyenes 
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remain a class of drug for which resistance is very uncommon (Sanguinetti et al., 2015). Poorer 
clinical outcomes and increased treatment costs are direct consequences of drug resistance. Given 
the increase in rates of drug resistance, it is incredibly important to understand the molecular 
mechanisms of pathogenesis in fungi such as C. albicans in order to work toward the development of 
novel antifungals. 
 
The yeast cell wall  
 While fungi such as C. albicans share considerable homology with humans, the fungal cell 
wall is an entire organelle not present in human cells, making it an ideal target for antifungal agents 
(Kitamura, Someya, Hata, Nakajima, & Takemura, 2009). The C. albicans cell wall is approximately 
90% carbohydrate (25-30% mannans, 40% β-1,3-glucan, 20% β-1,6-glucan, and 1-2% chitin) and 
10% protein (Gow & Hube, 2012; Klis, Groot, & Hellingwerf, 2001). The carbohydrates are 
typically the components recognized by the host immune system, while the proteins are involved in 
surface adhesion and other interactions with the host cell surfaces. There are three polysaccharide 
forms present in the cell wall: mannans, β-glucans, and chitin. Mannoproteins form the outer layer 
of and some mannan may exist in a free state within the cell wall. β-glucans, the most abundant 
Figure 1. Transmission electron microscope image and diagram of the C. albicans cell wall (Gow 
& Hube, 2012). 
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component of the yeast cell wall, exist as either β-1,3 glucans, which are strongly proinflammatory 
and form a more inner layer, and β-1,6 glucans, which act as a linker molecule between this layer and 
the mannan layer (Cid et al., 1995). Together with chitin (and its deacetylated form chitosan) the β-
glucans provide the rigid structure of the cell wall. Mannans (the polymerized form of individual 
mannose residues) are less structured, but have low permeability and porosity. Therefore, while they 
do not influence cell shape, the mannans influence the resistance of the wall to attack by host 
molecules (Gow & Hube, 2012). A diagram of the cell wall is shown in Figure 1.  
The pathway by which β-glucans are synthesized in C. albicans has yet to be fully elucidated. 
Fortunately, cell wall pathways are relatively conserved among fungi and putative pathways have 
been developed for C. albicans based off studies in Saccharomyces cerevisiae as well as additional work 
Figure 2. Proposed pathway of β‐1, 6 glucan synthesis (Shahinian & Bussey, 2000). 
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conducted in C. albicans itself (Nett et al., 2011). Shahinian and Bussey (2000) developed such a 
pathway describing the synthesis of β‐1,6-glucan, shown in Figure 2. Though β‐1, 6 and β‐1, 3 
glucans are synthesized in different pathways, there may be some commonalities, including the fact 
that both polysaccharides are believed to be synthesized from UDP-glucose (Nett et al., 2011). 
The pathway for β‐1,3-glucan synthesis is less clear, though four particular downstream 
components of the protein kinase C (PKC) pathway have been implicated. FKS1 and FKS2 are 
believed to act redundantly on UDP-glucose. In S. cerevisiae, disruption of either gene is viable, but 
disruption of both is lethal. In C. albicans, disruption of FKS1 is lethal, but disruption of FKS2 is not. 
These genes are regulated by way of transcription factor RLM1, which is thought to be activated by 
SMI1. The function of SMI1 is not fully known, but there is evidence that it plays a role in both β-
glucan production and deposition. The SMI1 knockout has enhanced antifungal susceptibility, 
thinner cell walls, a 4-fold reduction in biofilm β-glucans, and a 50% reduction in FKS1 transcripts. 
The study of β‐glucans is particularly important as these cell wall components have been shown to 
play a role in biofilm-specific drug resistance, possibly by sequestering drugs, thus preventing them 
from reaching the pathogen cells (Nett et al., 2011). 
 
Pattern-recognition receptors (PRRs) 
In order to combat pathogens such as C. albicans, immune cells employ pattern recognition 
receptors (PRRs) to identify conserved structures in microbes. These structures are termed 
pathogen-associated molecular patterns (PAMPs). PRRs may also recognize damage-associated 
molecular patterns (DAMPs), endogenous molecules released by damaged host cells that signal 
infection (Takeuchi & Akira, 2010). Recognition of C. albicans is primarily based on cell wall 
components (Jouault et al., 2009). Defense against organisms such as C. albicans is complex, and 
multiple cell types, PRRs, and signaling pathways all play a role (Netea & Maródi, 2010). PRRs may 
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be expressed in a number of immune cells, including macrophages and dendritic cells (Takeuchi & 
Akira, 2010). 
The PRRs known to 
play a major role in yeast 
recognition are shown in 
Figure 3, along with the 
structures they recognize. 
Note that both Dectin-1 and 
MR interact with TLR2 and 
induce a pro-inflammatory 
response when activated 
(Jouault et al., 2009). 
Interestingly, the pro- 
inflammatory response induced by recognition of C. albicans is necessary for the establishment of 
infection (Jouault et al., 2009). There are four families of PRRs: toll-like receptors (TLRs), C-type 
lectin receptors (CLRs), RIG I-like receptors (RLRs), and NOD-like receptors (Takeuchi & Akira, 
2010). This study focuses primarily on two CLRs: Dectin-1 and the mannose receptor (MR), which 
are encoded by the genes CLEC7A and MRC1, respectively. CLRs recognize polysaccharide 
structures on pathogens. These receptors play a central role in the recognition of fungal pathogens 
and help to induce the innate immune response (Netea & Maródi, 2010). 
The primary PRR for β-glucans is Dectin-1, which is mostly expressed in myeloid cells such 
as monocytes and macrophages (Saijo et al., 2007; Netea & Maródi, 2010). The precise role of β-
glucans in antifungal immunity is unclear. However, interactions between Dectin-1 and β-glucans are 
known to trigger the inflammasome complexes in host cells (Gow & Hube, 2012). Following 
Figure 3. Diagram of major host PRRs and the yeast structures 
they recognize (Jouault et al., 2009). 
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recognition of β-glucans by Dectin-1, the host cell engulfs the pathogen via phagocytosis and 
signaling pathways trigger the release of pro-inflammatory cytokines and the production of reactive 
oxygen species (Huang et al., 2012; Gantner, Simmons, & Underhill, 2005). Specifically, Dectin-1 
signals via Syk kinase and CARD9, which in turn induces pro-inflammatory signaling via IL-2 and 
IL-10 (Netea & Maródi, 2010). The Dectin-1 pathway is nonredundant and not compensated by 
other PRRs (Gow et al., 2007). There are two conflicting models for how Dectin-1 triggers 
phagocytosis. In the “trigger model,” Dectin-1 activation directly initiates phagocytosis, and this is 
the model most supported by present data. However, the alternative “zipper model” suggests that 
additional receptors are involved to coordinate phagocytosis following pathogen recognition by 
Dectin-1 (Gantner et al., 2005).  
Various studies have attempted to elucidate the role of Dectin-1 using in vitro and in vivo 
models. Dectin-1 deficient leukocytes have been shown to demonstrate a significantly impaired 
response to fungal pathogens (Taylor et al., 2007). Dectin-1 knockout mouse models have yielded 
conflicting results, with mutant mice demonstrating increased mortality in some models but not 
others (Huang et al., 2012). In a study by Taylor et al. (2007), Dectin-1 knockout mice demonstrated 
decreased survival and higher fungal burden in response to C. albicans infection. However, a 
subsequent study by Saijo et al. (2007) using a different mouse line found the knockout mice equally 
susceptible to infection by C. albicans, but did find a greater susceptibility to Pneumocystis infection 
(Netea & Maródi, 2010). These conflicting results reflect the complex nature of pathogen 
recognition and indicate the need for further studies into Dectin-1 and other PRRs. 
There is an interesting relationship between C. albicans morphology and activation of 
Dectin-1. As shown in Figure 1 and described previously in the text, β-glucans are largely shielded 
by outer cell wall components such as mannans. However, yeast budding and cell separation results 
in “bud and birth scars” which expose β-glucans. In the hyphal form, filamentous growth results in 
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no such separation and as a result, Dectin-1 is unable to recognize the pathogen (Gantner et al., 
2005). 
MR is another C-type lectin receptor that recognizes molecules with terminal mannose 
residues, including mannans (Dan et al., 2008). MR mediates phagocytosis by macrophages 
following recognition of mannan (Jouault et al., 2009). This activation also results in production of 
cytokines such as IL-17, which controls the neutrophil-mediated inflammatory response and induces 
protective Th17 response (van de Veerdonk et al., 2009; Netea & Maródi, 2010). In contrast to 
Dectin-1, the expression of mannans at the cell surface means that MR recognition of C. albicans is 
unlikely to be dependent on cellular morphology (van de Veerdonk et al., 2009). Furthermore, a 
study by Gow et al. (2007) found that in recognition of live C. albicans, mannans have the dominant 
role in immune stimulation, not β-glucans. This is rather logical, given that mannans are more 
external and more easily accessible by host PRRs.  
As with Dectin-1, multiple studies have been performed to understand the role of MR in vivo. 
An in vivo infection experiment conducted by Lee, Zheng, Clavijo, & Nussenzweig (2003) used MR-
deficient mice and found no significant difference in mortality between WT and MR -/- mice. 
Furthermore, this study found that MR -/- murine macrophages were not impeded in their ability to 
uptake C. albicans via phagocytosis. Interestingly, the authors found that addition of β-glucan could 
block phagocytosis. Based on these data, they concluded that MR is not required for host defense 
and that a β-glucan receptor likely plays a more prominent role, in opposition to the findings by 
Gow et al. (2007) that MR plays the dominant role in yeast recognition. However, Lee et al. (2003) 
did observe higher fungal burdens in some organs of the mice, despite the comparable mortality. 
Others have questioned the methods used in this study, as the C. albicans challenge was administered 
intraperitoneally, a method with little clinical relevance. Additionally, the inhibition of Candida 
uptake caused by mannans is stronger than β–glucan-induced inhibition (Netea & Maródi, 2010). A 
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similar study by Dan, Kelly, Lee, & Levitz (2008) subjected MR -/- mice to a pulmonary Cryptococcus 
neoformans challenge and observed higher mortality and higher pulmonary fungal burden in the MR -
/- mice. However, no difference was found with infection by Pneumocystic carinii. It is possible that 
this difference is due in part to soluble mannosylated ligands released from C. neoformans, initiating a 
more robust response. Given the conflicting nature of some of these findings, further research is still 
necessary in order to determine how significant a role MR plays in C. albicans infection. 
Dectin-1 and MR may interact during fungal recognition and phagocytosis, though this 
mechanism has not been studied in depth. One way in which MR activity may actually assist in 
Dectin-1 activation is by helping to expose β–glucans. Researchers have speculated that the initial 
host inflammatory response brought about by MR activation likely helps to degrade the outer 
mannan layer, at which point β–glucans become exposed, resulting in a further amplified immune 
response (Netea & Maródi, 2010). The Dectin-1-TLR2 complex has also been found to augment 
MR-induced IL-17 secretion (van de Veerdonk et al., 2009). Because of this, it would be valuable to 
conduct further research examining both receptors at once, such as using a double knockout. 
As seen in Figure 3, there are a number of receptors in addition to Dectin-1 and MR that 
play a role in recognition and phagocytosis of C. albicans. Other CLRs include Dectin-2, Galcetin-3, 
DC-SIGN, and DC-SIGNR. Dectin-2 recognizes structures with high mannose content and induces 
TNF production. It likely plays a role in hyphal recognition (Netea & Maródi, 2010). In dendritic 
cells, activation of Dectin-1 or Dectin-2 causes the cell to interact with T cells and instruct them to 
confer immunity against C. albicans (Takeuchi & Akira, 2010). Galectin-3 recognizes specific β-1,2 
mannosides specific to Candida (Jouault et al., 2009). DC-SIGN and DC-SIGNR are two related 
receptors expressed mainly in dendritic cells that also detect structures with high mannose content 
(Netea & Maródi, 2010).  
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In addition to CLRs, multiple TLRs including TLR2, TLR4, and TLR9 are involved in C. 
albicans PAMP recognition. These TLRs have also been shown to interact with other receptors such 
as Dectin-1 and MR (Netea & Maródi, 2010). The two TLRs most involved in C. albicans recognition 
are TLR2 and TLR4 (Jouault et al., 2009). Blocking TLR2 leads to decreased production of TNF, 
IL-10, and IL-1β as well as increased production of IL-12 and IFNγ following stimulation by C. 
albicans. Contrary to expectations, TLR2 -/- mice demonstrate increased resistance to C. albicans and 
TLR2 -/- macrophages are enhanced in their ability to contain C. albicans in vivo. These results 
indicate that TLR2 activation induces an immunosuppressive effect (Netea & Maródi, 2010). TLR4 
recognizes mannans in yeast as well as lipopolysaccharides in bacteria. However, not all strains of C. 
albicans are recognizable to TLR4. TLR4-defective mice are more susceptible to infection, produce 
fewer chemokines, and demonstrate impaired recruitment of neutrophils (Netea & Maródi, 2010). 
TLRs have also been shown to form complexes with other PRRs. Dectin-1 most likely 
forms a co-receptor complex with TLR2 (Gow & Hube, 2012). Several studies have indicated that 
collaboration with other PRRs, primarily TLR2, is required for proper signaling via Dectin-1 (Netea 
& Maródi, 2010). Dectin-1 interacts with TLRs in order to induce pro-inflammatory signaling. 
Simultaneous activation of Dectin-1 and TLR2 leads to a significant increase in the production of 
cytokines such as TNFα and IL‐12 (Gantner et al., 2005). MR has also been shown to associate with 
TLR2 following stimulation by certain fungi such as Pneumocystis and Galectin-3 associates with 
TLR2 during pathogen recognition as well (Jouault et al., 2009). The number of receptors involved 
in yeast recognition and the complexity of interactions between different PRRs makes understanding 
host-pathogen interactions of C. albicans a difficult but important task. 
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Secreted aspartyl 
proteases (SAPs) 
 While host immune 
cells use PRRs to identify 
C. albicans, C. albicans in 
turn uses numerous 
virulence factors to invade 
and damage host cells. 
These are represented as 
pink circles in Figure 1. 
Previous work in our lab 
and a collaborator lab at 
the Broad Institute has focused on one family of virulence factors called secreted aspartyl proteases 
(SAPs). RNA-seq data has demonstrated that SAP genes, especially SAPs 5 and 6, are upregulated in 
C. albicans cells which successfully overcome phagocytosis by macrophages (Delorey, data not 
published). These results point toward a key role played by SAPs 4-6 in pathogenesis by directly 
preventing macrophage killing. Figure 4 is a graph of transcriptional data for SAP5 in live C. albicans 
and shows that SAP5 expression is significantly upregulated at 4 hours in cells that have been 
internalized by macrophages. Working off of this and other data, a logical next step would be to 
quantify survival of C. albicans lacking SAP genes in an infection assay. 
In C. albicans, ten genes encode for SAP preproenzymes which gain approximately 60 amino 
acids when processed in the secretory pathway, which occurs concurrently with transportation. 
These proteins facilitate adhesion and invasion by distorting host cell membranes, digest foreign 
molecules for nutrient acquisition, and digest immune cells to evade attack. SAPs are produced by 
Figure 4. SAP5 transcription in live C. albicans over time. Mean of 
3 biological replicates and standard error of mean (SEM) plotted. 
Significance within groups is calculated by comparing each sample to 
the ten minute control for that group. One-way ANOVA, multiple 
comparisons. * = p ≤ .05, ** = p ≤ .01, *** = p ≤ 0.001, **** = p ≤ 
0.001 (Delorey, data not published). 
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post pathogenic Candida species, including C. tropicalis and C. parapsilosis, though many of these have 
significantly fewer SAP genes than C. albicans. Non-pathogenic or minimally pathogenic Candida 
species produce insignificant quantities of protease, even though many possess SAP genes. Even 
within C. albicans, protease production is associated with virulence, as clinical isolates from patients 
with vaginal candidiasis were 1.5- to 2-fold more proteolytic than isolates from asymptomatic 
carriers. Additionally, more proteolytic strains have been showed to adhere more strongly to human 
epithelial cells (Naglik et al., 2003) 
While there are four types of protease (the other three being serine, cysteine, and 
metalloproteases), SAPs are the only secreted protease in Candida. Interestingly, these SAP genes are 
among the mere 6-7% of genes in C. albicans with no homologs in S. cerevisiae. Figure 3 shows a 
dendogram of the 10 C. albicans SAP genes. The two clusters at the top, SAPs 1-3 and SAPs 4-6, 
have historically been the most studied. Simplistically speaking, yeast cells predominantly express 
SAPs 1-3, whereas hyphal cells predominantly express SAPs 4-6. Expression of SAPs 4-6 is not only 
associated with hyphal formation, but these processes 
have been found to be coordinately regulated. These 
three SAPs are up to 89% identical, and the optimal pH 
for their activity is 5.0. This is an important characteristic, 
as the pH of macrophage phagolysosomes is typically 
between 4.7-4.8 (Naglik et al., 2003). 
Additional studies have provided evidence for the 
role of SAPs 4-6 in pathogenesis. The sap456 -/- triple 
mutant has been shown to exhibit reduced invasiveness, 
though it is still able to form hyphae (Naglik et al., 2003). 
After phagocytosis by murine peritoneal macrophages, SAPs 4-6 but not SAPs 1-3 are upregulated 
Figure 5. Dendogram of SAP genes 
in C. albicans (Naglik et al., 2003). 
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and the sap456 -/- mutant is significantly more susceptible to phagocytosis than the wild-type, with 
53% more mutant cells eliminated in killing assays. It is currently unknown whether these proteins 
act directly on phagolysosomal enzymes involved in microbial killing or on other key enzymes 
involved in macrophage metabolism (Borg-von Zepelin, Beggah, Boggian, Sanglard, & Monod, 
1998). In this project, these results are expanded upon using single SAP knockout strains and triple 
knockout sap123 -/- and sap456 -/- strains. 
 
Further elucidating host-pathogen interactions 
  In this Major Qualifying Project, the roles of yeast SAPs and macrophage receptors in host-
pathogen interactions were explored by using mutants of both C. albicans and murine macrophages. 
First, wild-type SC5314 was tested in a macrophage invasion assay along with four macrophage cell 
lines: wild-type (WT), Dectin-1 (D1) knockout, MR knockout, and the double knockout of both 
Dectin-1 and MR. C. albicans was expected to have a higher percent survival when plated with 
macrophages lacking these receptors, as they would be impaired in their ability to recognize and 
phagocytize the pathogen (Fig. 6C). 
Next, to provide further evidence for the role of SMI1 in production of β-glucans and to 
reveal how β-glucan levels affect pathogenesis, engineering of a SMI1 knockout strain of C. albicans 
was attempted in order to assay this new strain with the four macrophage cell lines. Since the 
macrophage would have significantly fewer β-glucans to bind to, this C. albicans strain was expected 
to exhibit a higher survival rate than the wild-type. Percent survival against the D1 mutant should be 
comparable between WT and smi1 -/- C. albicans, since the macrophage cannot recognize the 
pathogen by β-glucans either way. Similarly, the highest survival is expected with the MR knockout 
macrophage line and the D1 MR double knockout, since both will be unable to recognize either 
mannans or β-glucans. 
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Finally, C. albicans knockout strains of SAPs 1-6 individually and the triple mutants sap123 -/-
and sap456 -/- were assayed against the same macrophage cell line set. C. albicans lacking SAP genes 
were hypothesized to exhibit decreased survival since they will be impaired in their ability to degrade 
macrophage host proteins and thereby escape phagocytosis (Fig. 6B). Based on prior RNA-seq data, 
we expected SAPs 5 and 6 to play the greatest role in overcoming phagocytosis, since these genes 
were the most upregulated in live C. albicans exposed to macrophages. Furthermore, the triple 
mutants were expected to have the poorest survival, as the lack of multiple SAP proteins would 
further reduce their defenses. Overall, the results of this project will provide important insight into 
how C. albicans interacts with host immune cells. Understanding such mechanisms is integral if we 
are to develop novel therapeutics to treat infections caused by this pathogen.   
Figure 6. Summary of host-pathogen interactions and major hypotheses 
of this project. (A) Immune cells such as macrophages use PRRs to 
recognize C. albicans and internalize them via phagocytosis, where the 
pathogen may either be degraded or escape through filamentation and 
the use of SAPs to degrade host proteins. (B) C. albicans lacking SAPs 
are expected to have a reduced capacity to escape, leading to decreased 
survival rates. (C) Macrophages lacking PRRs should be less able to 
recognize the pathogen, resulting in increased C. albicans survival. 
21 
 
METHODS 
Macrophage invasion assay 
In order to investigate host-pathogen interactions, a macrophage invasion assay was used to 
quantify survival rates of C. albicans when plated alongside murine macrophages. Macrophages were 
received from the Levitz Lab at UMass Medical School and included the wild-type NR-9456 (WT) as 
well as mutants lacking the Dectin-1 receptor (D1), the mannose receptor (MR), or both (D1 MR). 
RAW 264.7 cells were also used as an additional control. Strains of C. albicans used included wild-
type SC5314 as well as mutants lacking individual SAP genes 1-6 (sap1 -/- through sap6 -/-) as well 
as triple knockouts sap123 -/- and sap456 -/-. 
The assay was performed according to a protocol adapted from da Rosa, Boyartchuk, Zhu, 
& Kaufman (2010). Macrophages were grown in DMEM containing 10% fetal bovine serum (FBS), 
100 units/ml penicillin, and 100 μg/ml streptomycin at 37° C and 5% CO2. These cells were plated 
at a density of 2×106 cells/well in 9.6 cm2 wells using six-well plates. After one hour of incubation so 
that the cells could adhere, C. albicans was added at a 1:15 ratio (1.33×105 cells/well) for a final 
volume of 2 ml per well. Plates were spun down for three minutes at 3000 rpm to further facilitate 
cell adhesion, since we initially observed PRR mutants failing to adhere as well as the WT 
macrophages. Plates were incubated for approximately 8 hours and cells were scraped and collected 
in 8 ml 0.02% Triton X-100 to lyse the macrophages. Finally, a 10-2 dilution of the Triton X-100 cell 
suspension was plated on YPD and incubated for 24 hours at 37° C. The number of colony forming 
units (CFU) was counted and percent survival was calculated based on the number of CFU present 
for the C. albicans samples grown in parallel without macrophages. All conditions were done in 
triplicate (n=3) and some macrophage-C. albicans combinations were assayed a second time (n=6) to 
verify results.  
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Results gathered on different days were compared by normalizing all data to a “WT/WT” 
control of SC5314 (WT) C. albicans with WT macrophages. For each sample, normalized survival 
was calculated as the ratio of the observed raw percent survival to the percent survival for the 
WT/WT control on that day. Statistical significance was calculated using a two-tailed Student’s t-
test. 
 
β-glucan modified ELISA 
 In order to measure the total cellular levels of β-glucan in the various C. albicans strains used, 
a modified ELISA was used, following a protocol from Pablo Reyes-Gutierrez. All spin-down steps 
were 5 min at 4200 rpm (3000g) unless otherwise stated and were followed by discarding the 
supernatant. Yeast cultures, grown overnight in a 96-well plate, were killed by incubation in boiling 
water for 5 min. Plates were spun down, cells were resuspended in 50 μl PBS containing 2% BSA, 
and plates were incubated at room temperature for one hour using a swinging mixer. Plates were 
spun down again and cells were resuspended in 50 μl of the antibody solution (antibody against 
either 1,3- or 1,6-β-glucan), then incubated at 37º for one hour on a swinging mixer. Plates were 
spun down and wells were washed three times with PBS containing 0.05% Tween-20 (PBS-T), with 
cells being resuspended and spun down for 3 min at 4200 rpm after each wash. Cells were then 
resuspended in 50 μl of the secondary antibody solution (2 μg/ml goat anti-human HRP-conjugate 
antibody for 1,6-β-glucan or 1 μg/ml rabbit anti-mouse HRP-conjugate antibody for 1,3-β-glucan). 
Plates were incubated at 37º for one hour on a swinging mixer and again spun down. All wells were 
washed three times with PBS-T and finally resuspended in 50 µl/well chemiluminescent peroxidase 
substrate. Luminescence was measured in a microplate reader. 
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CRISPR/Cas9 gene knockout 
 The protocol used for the attempted CRISPR-mediated knockout of SMI1 was adapted 
from Vyas, Barrasa, & Fink (2015). The SMI1 gene was selected since it is putatively involved in β-
glucan production and deposition, and knocking it out still produces a viable organism (Nett et al., 
2011). Guide RNAs were identified by searching the database provided in the Vyas et al. (2015) 
supplement for sequences specific to both alleles of SMI1 and containing the NGG protospacer 
adjacent motif (PAM). In addition to SMI1, guide sequences for ADE2 were also used as a positive 
control, as ADE2 knockout was successfully achieved in the study by Vyas et al. (2015). Primers 
were then designed based on the sequence of the pV1393 plasmid used in this study, such that the 
top strand was of the format ATTTGN20G and the bottom strand was of the format AAAACN20C, 
where N20 is the guide sequence (not including the PAM). Repair templates were made by identifying 
a 100 bp region centered on the cut site, designing two 60 nt oligos with a 20 bp overlap, and 
extending these oligos using PCR. In these repair templates, the PAM site was mutated to add a 
unique restriction site (EcoRI) and a stop codon was added as well to knock out the gene. All 
primers and oligos used in this study are given in Table S1. 
 DH5α competent Escherichia coli were transformed with the plasmid obtained from Valmik 
Vyas at the Whitehead Institute Fink Lab in order to grow a stock of the plasmid. Successful 
transformants were selected for on LB plates containing 50 μg/ml nourseothricin (Nat) and 200 
μg/ml ampicillin (Amp). Liquid cultures were grown from single colonies and the plasmid was 
obtained by miniprep using a QIAprep Spin Miniprep Kit. Concentration was obtained using a 
Nanodrop machine. 
 Guide sequences were next cloned into plasmid pV1393, the map of which is shown in 
Figure S1. 2 μg of plasmid was digested per reaction by combining it with 5 μl 10x NEB3.1 buffer, 1 
μl BsmBI, and water to 50 μl. This mixture was incubated for 20 min at 55° C, cooled to room 
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temperature, spun down, 1 μl CIP was added, and then it was incubated at 37º C for one hour. To 
purify this sample, a QIAquick Gel Extraction Column was used, eluting in 30 μl buffer EB and 
again using the Nanodrop to measure the concentration. Guide oligos were phosphorylated and 
annealed by adding to a PCR tube 0.5 μl of each the top and bottom strands (stock concentration 
100 μM), 5 μl 10x T4 ligase buffer, 1 μl T4 polynucleotide kinase, and 43 μl water. This was 
incubated in a thermocycler for 30 min at 37° C then 5 min at 95º C and finally cooled to 16° C on 
the slowest ramp available. These guide oligos were then ligated into the cut plasmid by combining 
in a PCR tube 1 μl 10x T4 ligase buffer, 0.5 μl ligase, 0.5 μl annealed oligos, 20-40 ng pV1393, and 
water to 10μl, then incubating in a thermocycler for 30 min at 16° C, 10 min at 65º C, then cooling 
to 25º C. DH5α E. coli was transformed with this recombinant plasmid and successful transformants 
were selected for as described above. 
 Selected colonies were miniprepped as described above, and successful cloning was verified 
by performing two diagnostic digests, an EcoRI digest and a double digest with BsmBI and BglII. 
The digested plasmid was then subject to gel electrophoresis. Plasmids extracted from colonies that 
were determined to have the guide sequence successfully cloned in were then used to transform C. 
albicans using a lithium acetate transformation protocol. pV1393 was linearized by SacI-HF and 
KpnI-HF double digest, and 1-2 μg of the linearized plasmid was used in the transformation along 
with 6-8 μg of repair template. C. albicans transformants were selected for on YPD plates containing 
200 μg/ml Nat.  
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RESULTS 
Comparison of cell lines used in this study 
 In order to verify that the NR-9456 macrophage cell line (WT) is a viable alternative to the 
more commonly used RAW cells, cell morphology and ability to clear C. albicans were compared 
between the two cell lines. Under the microscope, WT and RAW cells appear similar in morphology, 
with cells taking on a variety of shapes ranging from circular to spread out with visible pseudopods, 
as shown in Figure 7. However, it is noteworthy that, over time, the WT macrophages displayed a 
greater range of morphologies, such as forming dense microcolonies and highly elongated cells, 
whereas RAW morphology was more or less constant over time. The mutant cell lines exhibited 
traits similar to the isogenic WT, including temporal variations, but overall had a higher frequency of 
Figure 7. Morphological comparison of  macrophage cell lines used in this study. Microscope 
images of  RAW cells at 100x (A) and 400x magnification (B) and WT NR-9456 cells at 100x (C) 
and 400x (D) magnification. 
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the circular morphology. Next, survival rates of each C. albicans strain used in the study were 
compared between the two cell lines. As shown in Figure 8, there was no significant difference 
between the two cell lines for all C. albicans strains except SC5314 and the sap456 -/- triple knockout 
isolate B. Overall, the trends in C. albicans survival increases and decreases in survival were 
comparable for both WT and RAW cells. 
The macrophage invasion assay protocol was used to measure the survival of each C. albicans 
strain when plated with each macrophage cell line. As described in the methods section, percent 
survival was calculated by determining the ratio of the number of CFUs for each sample to the 
number of CFUs of C. albicans of that strain grown in parallel without macrophages. These data were 
used in two ways: to determine the effect of SAP gene knockout on C. albicans survival for each 
macrophage cell line and to determine the effect of macrophage PRR knockout on survival for each 
individual C. albicans strain.  
 
Figure 8. Comparison of  WT macrophage (orange) and RAW 264.7 (gray) profiles with respect 
to the effect of  SAP gene knockout on C. albicans survival after 8 hours macrophage-C. albicans 
co-culture. Mean of  3 biological replicates (exceptions: n=6 for RAW SC5314 and n=28 for WT 
SC5314) and SEM plotted. Significance within groups calculated by 2-tailed t-test comparing WT 
and RAW cell lines for that C. albicans strain. * = p<.05, ** = p<.01, *** = p<.001. 
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Effect of C. albicans SAP knockout 
 In Figure 9, the survival for each SAP mutant is compared to the survival of SC5314 for 
each macrophage cell line to test the hypothesis that C. albicans lacking SAPs will be impaired in their 
ability to defend against phagocytosis and thereby exhibit decreased survival. For WT macrophages, 
knocking out SAPs 1, 2, 4, and 5 significantly reduced C. albicans survival and this decreased was 
greatest for sap4 -/- and sap5 -/-. There was also an observed decrease for SAPs 3 and 6, though it 
was not significant. Interestingly, the survival rate for sap123 -/- and sap456 -/- isolate A were 
approximately equal to the survival of SC5314 (Fig. 9A). For RAW cells, there was a significant 
decrease in survival for sap5 -/- and a significant increase for both sap456 -/- isolates (Fig. 9B.) The 
D1 knockout macrophages had decreases in survival for all SAP single mutants, which was 
significant in sap3 -/- and sap4 -/-. Survival increases were observed for sap123 -/- and sap456 -/- 
isolate A (Fig. 9C). All SAP mutants exhibited decreased survival when exposed to the MR knockout 
macrophages. This decrease was statistically significant for sap1 -/-, sap2 -/-, sap3 -/-, sap123 -/-, sap6 
-/- and both sap456 -/- isolates and was greatest for knockouts of SAPs 1-3 (Fig. 9D). For the D1 
MR double knockout cell line, only sap3 -/- showed a significant decrease in survival (Fig. 9E). Note 
that, in general, the survival rates of the triple mutants were inconsistent with those of the single 
mutants for the same macrophage type, and the two isolates of sap456 -/- exhibited profiles 
inconsistent with each other.  
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Effect of macrophage PRR knockout 
 The same data from Figure 9 was analyzed again to compare survival for each C. albicans 
strain plated with various macrophage line to test the hypothesis that macrophages lacking the PRRs 
D1 and MR are less effective at clearing C. albicans. This comparison is shown graphically in Figure 
10. For wild-type C. albicans SC5314, survival was increased significantly with the MR knockout 
macrophage, and slightly (not significantly) for the D1 knockout as compared to WT (Fig. 10A). A 
survival increase was also observed for the MR in sap4 -/- and sap5 -/-, which was significant in the 
former and, interestingly, there was a decrease in MR for sap3 -/- and sap456 -/- isolate A (Fig. 10D, 
F, G, I). Unexpectedly, there was a significant survival decrease for the D1 MR double knockout cell 
Figure 9. Effect of  SAP gene knockout on C. albicans survival when grown for 8 hours with WT 
macrophages (A), RAW 264.7 cells (B), D1 KO macrophages (C), MR KO macrophages (D), and 
D1 MR dKO macrophages (E). Mean of  3 biological replicates (exceptions: n=6 for WT SAP456a, 
RAW SC5314, RAW SAP456a, D1 SAP456a, and D1 MR dKO SC5314; n=9 for D1 SC5314; n=28 
for WT SC5314) and SEM plotted. Significance calculated by 2-tailed t-test comparing each sample 
to the SC5314 sample for that macrophage cell line. * = p<.05, ** = p<.01, *** = p<.001. 
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line in SC5314 as well as sap3 -/-, sap123 -/-, and sap456 -/- isolate B (Fig. 10A, D, E, J). There were 
no significant differences in survival between the five macrophage cell lines used in this study for 
sap1 -/-, sap2 -/-, sap5 -/-, and sap6 -/- (Fig. 10B, C, G, H). 
 
Quantification of total β-glucan in SAP mutants  
 As a control to validate the assumption that β-glucan levels would be approximately equal 
between the SAP knockout strains and SC5314, a modified ELISA was used to quantify the levels of  
β-1,3-glucan and β-1,6-glucan for each C. albicans strains used in this study. Contrary to expectations, 
while levels of  β-1,3-glucan remained approximately equal for the single SAP mutants as compared 
with SC5314, the levels of  β-1,6-glucan increased for knockouts of  SAPs 2-6, and this increase was 
Figure 10. Effect of  macrophage PRR knockout on C. albicans survival after 8 hours growth with 
macrophages, for the wild-type C. albicans strain SC5314 (A) and knockouts of  SAP1 (B), SAP2 (C), 
SAP3 (D), SAP123 (E), SAP4 (F), SAP5 (G), SAP6 (H), and SAP456 isolates A (I) and B (J). Mean 
of  3 biological replicates (exceptions: n=6 for SC5314 RAW, SC5314 D1 MR dKO, SAP456a WT, 
SAP456a RAW, and SAP456a D1; n=9 for SC5314 D1; n=28 for SC5314 WT) and SEM plotted. 
Significance calculated by 2-tailed t-test comparing each sample to the WT macrophage sample for 
that C. albicans strain. * = p<.05, ** = p<.01, *** = p<.001. 
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significant for sap5 -/- and sap6 -/-. The levels of  both β-glucans were elevated for the triple mutants, 
significantly so for β-1,3-glucan in sap456 -/- isolate A and β-1,6-glucan in both sap456 -/- isolates (Fig. 
11A). These data were used to calculate the ratio of  β-1,3-glucan to β-1,6-glucan for each strain. The 
1,3:1,6 ratio for SC5314 was approximately 4.5 and there were noticeable decreases in this ratio for all strains 
except sap1 -/- (Fig. 11B). 
 
Attempted SMI1 knockout 
 In order to knock out the SMI1 gene in C. albicans, plasmid pV1393 was grown up in E. coli 
and extracted by miniprep. Following digestion with BsmBI, guide sequences for either SMI1 or 
ADE2 (a positive control that turns C. albicans colonies red when knocked out) were cloned into 
pV1393, as described in greater detail in the Methods section. These plasmids with guide sequences 
were then again transformed to E. coli to grow a sufficient stock and plasmids were again extracted 
Figure 11. β-glucan ELISA results 
for all C. albicans strains used in this 
study. (A) Levels of  β-1,3-glucan 
(light green) and β-1,6-glucan (dark 
green) per cell as determined by 
modified ELISA. Mean of  6 
biological replicates and SEM 
plotted. Significance calculated by 
2-tailed t-test comparing each 
sample to the level of  either β-1,3-
glucan or β-1,6-glucan for SC5314. 
* = p<.05, ** = p<.01. (B) Ratio 
of  β-1,3-glucan to β-1,6-glucan for 
each C. albicans strain. 
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by miniprep. In order to confirm successful cloning, miniprep products were subject to digest by 
EcoRI or double digest by BsmBI and BglII (Fig. 12). Based on plasmid sequence, EcoRI was 
expected to digest pV1393 into fragments of 6.24, 2.605, 2.483, 1.812, and 0.493 kbp. Since a small 
portion of the plasmid is lost following successful cloning of a guide sequence, EcoRI should digest 
guide-containing pV1393 into fragments of 6.24, 2.605, 2.483, 2.307, and 1.335 kbp (Fig. S2). The 
adjacent BsmBI cut sites are also lost following insertion of the guide sequences, meaning that 
double digest by BsmBI and BglII should linearize the plasmid if the guide sequence has been 
cloned in correctly. However, if the guides were not cloned in, the BsmBI sites will still be present, 
resulting in two fragments of about 5.2 and 9.7 kbp. The total length of pV1393 is 15.0 kbp. Note 
Figure 12. Gel electrophoresis of digested CRISPR plasmid following insertion of guide 
sequences specific to SMI1 (top) and ADE2 (bottom). For each colony isolate, extracted plasmid 
was run on the gel following EcoRI digest (E), following BsmBI + BglII double digest (B), and 
uncut (U). DNA ladder III run in parallel with labeled fragment sizes in kilobase pairs.  
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that the EcoRI digest and BsmBI/BglII digest are two methods of verifying the same result: 
whether or not guides have been cloned in.  
 As shown in Figure 12, the plasmids extracted from SMI1 colonies 4, 7, and 8 as well as 
ADE2 colony 6 showed three bands, two at approximately 5 kbp and 10 kbp, and a third above 10 
kbp. This likely indicates a mixture of pV1393 with and without guide sequences cloned in present 
in the sample. These samples also had a band between 1.5 and 2 kbp for the EcoRI digest, as well as 
a band at approximately 0.5 kbp, both of which are characteristic of plasmids without guide 
sequences inserted. SMI1 colony 6 and ADE2 colony 5 had only one band in the B lane and lacked 
the 1.8 and 0.5 kbp bands in the E lane, characteristic of plasmids with the guide sequences. SMI1 
colony 5 and ADE2 colonies 4 and 7 also had this profile, but with an additional band in all three 
lanes (include uncut) between 2.5-3 kbp. Because of the presence of this unaccounted for DNA, 
only SMI1 c6 and ADE2 c5 were selected to move forward for transformation of C. albicans. 
 Unfortunately, four attempts at transformation of C. albicans yielded no positive results, as 
either no colonies grew or an approximately equal number of colonies grew for C. albicans 
transformed with these plasmids and corresponding repair templates as with C. albicans transformed 
in parallel with only the repair template. Additionally, the red colonies characteristic of ade2 -/- 
mutants were not observed (although following one transformation, pink colonies were observed on 
all plates and determined to be bacterial contamination). Possible reasons for the failure of this 
transformation and additional strategies to circumvent these issues are described in the discussion 
section.  
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DISCUSSION 
 The results of this Major Qualifying Project provide new evidence regarding the roles of C. 
albicans SAPs and the macrophage PRRs Dectin-1 and mannose receptor in phagocytosis and yeast 
survival. The use of a panel of macrophages with different mutations to assay multiple strains of C. 
albicans against was novel, and therefore it was necessary to verify that our isogenic wild-type was 
equivalent to a cell line commonly used in similar infection assays. RAW 264.7 cells are frequently 
used as an immortalized macrophage line. These cells were originally derived by Raschke, Baird, 
Ralph, & Nakoinz (1978) from tumors that had been induced in mice with the Abelson leukemia 
virus. By contrast, the NR-9456 line used in this study is an immortalized cell line derived from wild-
type mouse primary bone marrow cells (BEI Resources, 2014). We chose to use this cell line because 
primary bone marrow-derived cells should in theory be closer to macrophages in vivo encountered by 
C. albicans than tumor-derived cells. In support of this idea, there are substantial documented 
differences between RAWs and bone-marrow derived macrophages (BMDMs). Proteomic analysis 
comparing the two found that RAWs are greatly reduced in phagosomal functions including 
acidification and proteolysis. RAWs also expressed more Dectin-1 and less MR than BMDMs (Guo 
et al., 2015) 
WT NR-9456 and RAW 264.7 macrophages were found to have similar morphology and 
similar rates of clearance of the various C. albicans strains used in this study, indicating that NR-9456 
is a reasonable substitute (Fig. 7, Fig. 8). However, one important distinction was that C. albicans 
survived significantly less when plated with RAW as compared to WT (Fig. 8, Fig. 10A). As a 
consequence, only SAP5 exhibited a significant decrease in survival as compared with SC5314 for 
RAW cells, whereas multiple SAP mutants exhibited decreased survival with WT, described in more 
detail below (Fig. 9A-B). This difference is likely due to differences in cytokine production and 
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receptor expression in RAW cells and may raise some concerns about the accuracy of RAW cells in 
infection assays (Guo et al., 2015). 
This study is the first to show that BMDMs lacking either Dectin-1 or MR were impaired in 
their ability to eliminate C. albicans. Taylor et al. (2007) found that peritoneal macrophages lacking 
Dectin-1 were decreased in their ability to recognize, but not kill, C. albicans, though they did find a 
decrease in killing efficiency in D1-deficient leukocytes. Lee et al. (2003) found that MR -/- murine 
peritoneal macrophages phagocytosed C. albicans as efficiently as the wild-type, but did not measure 
C. albicans survival. As in the case of RAW cells, there are significant phenotypic differences between 
BMDMs and other macrophage types such as peritoneal macrophages (PEMs). A recent study 
found that PEMs and BMDMs are phenotypically distinct, and differ from macrophages in lesions 
with respect to expression of M1/M2 markers and lipid metabolism genes. (Bisgaard et al., 2016). 
Additionally, BMDMs were found to be more effective at phagocytosis and proliferated more 
robustly than PEMs or splenic macrophages (SPMs), and all three populations exhibited very 
different profiles of cytokine production. For example, PEMs expressed more of the pro-
inflammatory IL-12 (Wang et al., 2013). At present, it is unknown whether one cell line is more 
representative of the conditions encountered by pathogens in vivo, and it is therefore necessary to 
conduct in vitro studies using multiple lines as well as in vivo experiments in order to gain a more 
thorough understanding of these interactions.  
In addition to considering various macrophage cell lines, there are also variations within a 
given macrophage population. Macrophages are not phenotypically constant, but instead exhibit 
plasticity, able to polarize into activated subtypes. M1 (classically activated) macrophages are pro-
inflammatory whereas M2 (alternatively activated) macrophages are anti-inflammatory and play a 
role in clearing damaged tissue. Interestingly, while M1 macrophages demonstrate an enhanced 
ability to clear microbes, their phagosomes fail to acidify, while M2 macrophages reach a pH of less 
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than 5.0 (Canton, Khezri, Glogauer, & Grinstein, 2014). M2 macrophages have also been shown to 
have increased expression of both Dectin-1 and the mannose receptor (Martinez, Gordon, Locati, & 
Mantovani, 2006). It is important to note that tumor-derived macrophages such as RAWs are highly 
biased towards the M2 phenotype (Mantovani, Sozzani, Locati, Allavena, & Sica, 2002). This is 
another reason BMDMs may yield results with greater in vivo relevance, as they retain the potential to 
differentiate in a way lost by RAWs.  
In this study, macrophages lacking Dectin-1 and/or the mannose receptor were used to test 
the hypothesis that disruption of these receptors inhibits the macrophages’ ability to phagocytose 
yeast, leading to greater C. albicans survival. For wild-type C. albicans (SC5314), loss of Dectin-1 led to 
slightly increased survival (not significant, p=0.23) and loss of the mannose receptor led to 
significantly increased survival (p=1.4x10-4) (Fig. 10A). This may indicate that the mannose receptor 
plays a greater role in yeast recognition, which is somewhat logical given that mannans are on the 
outer surface of the cell wall (Fig. 1). However, past studies have yielded conflicting results as to 
which of these receptors play a greater role, and it is impossible to say with certainty to what extent 
these in vitro results translate to pathogen recognition in vivo, and some authors have cautioned 
against drawing such conclusions (Lee et al., 2003; Gow et al., 2007; Bisgaard et al., 2016).  
The D1 MR double knockout line was expected to produce the greatest yeast survival since 
it lacks both key receptors. However, survival of SC5314 with this line was significantly decreased 
(p=4.4x10-3) as compared with WT macrophages (Fig. 10A). As with the triple SAP mutants, this 
unexpected result may indicate a mistake in the cell line’s genetic engineering or a compensatory 
mechanism. However, I hypothesize that this decrease in survival stems from the relationships 
between D1, MR, and TLR2, as both D1 and MR are known to interact and form co-receptor 
complexes with TLR2 (Fig. 3; van de Veerdonk et al., 2009; Jouault et al., 2009). TLR2 binds 
phospholipomannans on C. albicans and multiple studies have found that macrophages lacking TLR2 
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are enhanced in their ability to contain C. albicans in vitro and in vivo (Blasi et al., 2005; Netea & 
Maródi, 2010). Blasi et al. (2005) posited that TLR2 inhibits the ability of macrophages to 
phagocytose C. albicans, possibly by interfering with other receptors. I argue that this inhibition is not 
caused by TLR2 alone, but by these known interactions between TLR2, D1, and MR. Thus, by 
knocking out both D1 and MR, we are essentially recreating the effect observed in TLR2 -/- 
macrophages. Further studies will be needed to confirm this relationship. Particularly, it would be 
interesting to see whether the cytokine production for the D1 MR dKO macrophages mirrors the 
differential cytokine production that has been observed for TLR2 -/- macrophages, including 
reduced IL-10 and increased IL-12 and INFγ production (Blasi et al., 2005; Netea & Maródi, 2010; 
Gantner et al., 2005). 
With respect to SAP genes, our initial hypothesis was that C. albicans lacking SAPs would 
exhibit decreased survival as compared with wild-type C. albicans (SC5314) when plated with 
macrophages and the results of this study generally supported this hypothesis. When plated with WT 
macrophages, C. albicans strains lacking SAPs 1, 2, 4, and 5 were significantly decreased in their 
survival rates (p=3.0x10-3, 1.3x10-2, 1.5x10-4, and 8.3x10-4, respectively) and SAPs 3 and 6 were 
insignificantly decreased (Fig. 9A). This indicates that these SAPs play an important role in helping C. 
albicans escape phagocytosis. Multiple SAP mutants also exhibited decreased survival with the mutant 
macrophages, indicating that a significant proportion of C. albicans are still phagocytosed by these 
receptor-lacking macrophages but are able to overcome phagocytosis through expression of SAPs 
(Fig. 9C-E). Overall, SAPs 1-3 and 4-6 exhibited similar trends within those two groups, which 
makes sense given that SAPs 1-3 share high homology, as do SAPs 4-6 (Fig. 5, Fig. 9). 
While survival was expected to be lowest for the sap123 -/- and sap456 -/- triple knockouts, 
the survival rates for these C. albicans strains were in fact generally greater than those of the single 
knockouts and greater than or equal to that of SC5314 for the same macrophage cell line (Fig. 9). 
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This may be evidence of a compensatory mechanism in which disruption of multiple SAP genes 
causes leads to an upregulation of other SAP genes or other virulence factors, or off-target effects 
caused by the genetic engineering. To further explore this outcome and verify results, two different 
isolates of sap456 -/- were used, deemed SAP456a and SAP456b. Use of these two strains frequently 
yielded conflicting results, most notably with the D1 KO and D1 MR dKO macrophages, where 
SAP456a had increased survival compared to SC5314, yet the survival of SAP456b was decreased 
(Fig. 9, Fig.10I-J). This difference makes it more likely that the cause of the unexpected results for 
the triple mutants is an issue in genetic engineering. Furthermore, the observed increase in survival is 
in oppositition to the findings by Borg-von Zepelin et al. (1998) that showed a 53% decrease in 
survival of their sap456 -/- strain as compared to SC5314, though there were some key differences in 
the protocol used. Specifically, the authors used PEMs instead of BMDMs, plated at a 5:1 
yeast:macropage ratio in contrast to the 1:15 ratio used in this study, and incubated the yeast and 
macrophages together for 90 minutes instead of the 8 hours used here. These differences make it 
difficult to directly compare results, and genome sequencing and transcriptional analysis of the triple 
knockout isolates used in this study would be useful to identify or rule out off-target mutations or 
differential gene expression that may be altering survival. 
In order to confirm that the results for the SAP mutants were not due to differences in the 
cell wall composition between strains, a modified ELISA was used to detect the levels of β-1,3- and 
β-1,6-glucan in each strain. While the levels of β-1,3-glucan did not increase in the single SAP 
mutants, β-1,6-glucan did increase for all single mutants except sap1 -/-, although this was only 
significant for sap5 -/- and sap6 -/-. Levels of both types of β-glucan were increased in the triple 
mutants (Fig. 11A). The calculated ratio of β-1,3- to β-1,6-glucan in SC5314 was approximately 4.5, 
consistent with the finding by Bowman & Free (2006) that 65-90% of the glucan content in the cell 
wall by dry weight is β-1,3-glucan. This ratio was greatly decreased in all SAP mutants except sap1 -/- 
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(Fig. 11B). However, these variations did not correlate with differences in yeast survival with D1-
deficient macrophages between C. albicans strains. Since β-1,3-glucan is the predominant glucan type 
and did not vary significantly between SC5314 and the single mutants, this is not surprising. Ideally, 
a similar assay will be used to quantify mannan levels across strains to make sure this is constant as 
well and not a cause of the results for the MR-deficient macrophages. It is also notable that levels of 
both β-glucans were highest for the triple mutants and the profiles of sap456 -/- isolates A and B 
were very different, giving further credence to the possibility that genetic engineering issues in these 
triple mutants may at least partially explain the unexpected results in these strains (Fig. 11A). 
One important future experiment will be to repeat the macrophage invasion assay for the 
SAP1-6 mutants in WT macrophages in order to determine the role of SAPs at time points earlier 
than 8 hours. If knocking out SAP genes has a significant effect on C. albicans survival at early time 
points (30 minutes, 1 hour), this may provide evidence that SAP proteins play a role in recognition. 
Furthermore, it is possible that SAPs 1-3 play a role later on in infection than SAPs 4-6, as SAPs 1-3 
are more active at a lower pH (3.2-4.5), which is what they are likely to encounter in acidified 
phagolysosomes, whereas SAPs 4-6 may work to degrade macrophage proteins even before being 
taken up by the macrophage (Naglik et al., 2003). Time course experiments would be valuable for 
exploring these hypotheses. 
 It is worth noting that initial attempts at the macrophage invasion assay resulted in high 
error and general decreases in C. albicans SC5314 survival for the mutant macrophage lines. It was 
observed that these mutant macrophages adhered poorly to the plates and retained a spherical 
morphology, whereas WT macrophages spread out flat along the plate. Since macrophages are 
highly motile, it was hypothesized that the observed decreases in survival were caused by the mutant 
cell lines being able to move about on the plate more freely and encountering more C. albicans as a 
result. To level the playing field between all macrophage cell lines, a spin down step was added to 
39 
 
the protocol following the addition of C. albicans. The addition of this step was key in obtaining the 
results of this study, and this is something future researchers may wish to consider when using 
macrophages with mutations of proteins on the cell wall or other components that may potentially 
alter their adherence. 
 Unfortunately, smi1 -/- C. albicans was unable to be tested using the macrophage invasion 
assay as the CRISPR genome editing was unsuccessful. Diagnostic digests indicated that, at least in 
certain miniprep samples, the guide sequence had been successfully cloned in (Fig. 12). However, 
these diagnoses only reveal that the 20 bp region between the two BsmBI cut sites had been excised 
from the plasmid and it is possible that the plasmid re-ligated. In this case, the C. albicans 
transformation would have resulted in nourseothricin-resistant colonies, but the intended mutation 
would not have occurred, meaning an absence of red ade2 -/- colonies for the control. Instead, there 
was no instance in which there were significantly more colonies on the transformation plates than 
the control plates in which the transformation protocol was followed with no plasmid. This indicates 
that the most likely issue is with the transformation protocol used, which was the lithium acetate 
method. Electroporation, alternative versions of the lithium acetate protocol, or hybrid lithium 
acetate-electroporation should be tried next, and additional controls should be implemented to 
verify the transformation protocol is working. Finally, the plasmids taken from the transformed E. 
coli may be sequenced to confirm that the proper guide sequences have, in fact, been inserted into 
the plasmid. 
 Understanding the host-pathogen interactions between C. albicans and immune cells is of 
great importance for designing novel antifungals and vaccines. A vaccine against SAP2 using a 
truncated version of the protein is currently in clinical trials, and SAPs 1 and 2 have been found to 
be highly upregulated in vaginal and oral candidiasis (De Bernardis et al., 2012). SAPs are an ideal 
vaccine target because they share minimal homology with any human proteins. However, this 
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vaccine will only allow the host to produce anti-SAP2 antibodies, and some have advocated for an 
approach targeting multiple SAPs at once. A past doctoral student in our lab previously found that 
knocking out SAPs reduced symptoms of C. albicans infection in the nematode C. elegans and 
identified a 35 residue domain common to all secreted SAPs but sufficiently divergent from even the 
most closely related human proteins. Furthermore, this domain lies on a highly exposed region of 
the protein, making it a perfect target for antibody binding (Issi, 2014). Understanding the relevance 
of SAPs in C. albicans infection is integral to their utilization as a vaccine target. 
Additionally, understanding the role PRRs play in infection is important, as 3-5% of women 
suffer from chronic yeast infections and the underlying genetic factors that predispose individuals to 
this type of infection are poorly understood (Naglik et al., 2003). Loss-of-function mutations in 
PRRs such as Dectin-1 or the mannose receptor may help explain this phenomenon. Overall, the 
results of this study have helped shed light on the roles of PRRs and SAPs in C. albicans infection. 
Further studies are still needed to understand the interactions between different PRRs and the 
effects of knocking out multiple SAPs at once. 
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APPENDIX A: Supplemental data 
The plasmid used for the CRISPR experiments, pV1393, was provided by Valmik Vyas and 
is a modified version of the Solo System plasmids used by Vyas et al. (2015). The map below shows 
the major features of the plasmid. The Cas9 gene encodes the protein used to target specific 
genomic sequences and make a double strand break at that location, which has been optimized for 
use in C. albicans. This protein is under the control of the ENO1 promoter. The NatR gene provides 
nourseothricin resistance and is used as a selection marker in C. albicans and E. coli, and AmpR 
provides resistance to ampicillin in E. coli. NatR may be excised by FLP-FRT recombination so that 
the system can be reused for multiple iterations of genome editing. The guide sequence specific to 
the gene of interest can be cloned in at the location labeled sgRNA on this map, and this is under 
the control of the SNR52 promoter. Relevant restriction sites are also shown. Double digest by 
KpnI and SacI is used to linearize the plasmid so that it may be integrated into the C. albicans 
Figure S1. Map of pV1393 containing inserted guide sequence with select features labeled, 
created using Serial Cloner. 
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genome. EcoRI, BglII, and BsmBI were used for 
diagnostic digests to determine successful insertion of 
the guide sites. For the EcoRI digest, the bands at 
1.812 and 0.493 kbp were used as a way to identify 
unsuccessful clones (Fig. 12, Fig. S2). Note that in 
pV1393 prior to insertion of the guide sequence, the 
sgRNA site contains two BsmBI cut sites and an 
EcoRI cut site. 
The oligonucleotides used as guide sequences, 
repair templates, and PCR primers were selected as 
described in the methods section. In brief, guide 
sequences unique to both alleles of SMI1 were 
selected from the supplement of Vyas et al. (2015) and three guides were chosen that were closer to 
the start of the open reading frame to more likely result in functional gene knockout. Repair 
templates were 100 bp strands centered on the planned double stranded break. In order to more 
likely ensure gene knockout, three guide sequences and three corresponding repair templates were 
designed for SMI1. The guide and repair template used for ADE2 were taken from Vyas et al. 
(2015). After multiple attempts at cloning each guide oligo into pV1393 and transforming E. coli 
with the recombinant plasmids, successful transformation was observed only for ADE2 and SMI1 
guide 1. The full list of oligos and primers used is given in Table S1. 
  
Figure S2. Diagram of expected results 
for diagnostic digest with EcoRI. 
Fragment lengths in kbp. 
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Table S1. Oligonucleotides and primers used in this study. 
Gene target Purpose Direction Sequence 
ADE2 guide forward atttgcaacaatcatacgacctaatg 
ADE2 guide reverse aaaacattaggtcgtatgattgttgc 
SMI1 guide (1) forward atttgtcattatcgtcatttctatag 
SMI1 guide (1) reverse aaaactatagaaatgacgataatgac 
SMI1 guide (2) forward atttgtattcattagataattctacg 
SMI1 guide (2) reverse aaaacgtagaattatctaatgaatac 
SMI1 guide (3) forward atttgcaattttataaacgtcatgag 
SMI1 guide (3) reverse aaaactcatgacgtttataaaattgc 
ADE2 repair template forward atggatagcaaaactgttggtattttaggaggttaatgattaggtcgta
tgattgttgaa 
ADE2 repair template reverse ttacggtcttgatattcaatctatgtgctgcttcaacaatcatacgacc
taatcattaac 
SMI1 repair template (1) forward ttcattcaattacaacagaagatcattatgcttcatatgattcataaga
attcaatgacg 
SMI1 repair template (1) reverse gttgatgacctatgagaattggtaccaattggttcattatcgtcattga
attcttatgaa 
SMI1 repair template (2) forward aatggaaatttgttgctaaatttgttaagagttataagtaatctattaag
atgaattctt 
SMI1 repair template (2) reverse gaacaactctactaaagtatggaccagatattttgggcttaagaattc
atcttaatagat 
SMI1 repair template (3) forward aatattcattagataattctactggtgcagcagggttttatagataaga
attcaaatcat 
SMI1 repair template (3) reverse ccattggcactaaaattttgtaatggtaaatcttgttgagatgatttga
attcttatcta 
ADE2 PCR primer forward aacaccccccaccaaaaagaatc 
ADE2 PCR primer reverse acaagtcatcgactgtgttgg 
SMI1 PCR primer forward ttgaaaaccagccactagtctcg 
SMI1 PCR primer reverse aagggctacccttctattggt 
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APPENDIX B: Protocol for CRISPR gene editing in C. albicans 
Adapted from Vyas et al. (2015). 
 
1. Select gene to target 
2. Design guide sequences and repair templates 
a. Guide sequence should be 23 bp unique to gene, including PAM (NGG) 
i. Order sequence minus PAM, plus nts to ligate into plasmid 
1. Forward strand: ATTTG[sequence minus PAM]G  
2. Reverse strand: AAAAC[reverse complement of sequence minus 
PAM]C  
ii. If going for knockout, select sequences which affect protein closer to N 
terminus 
iii. If going for knockout, make sure to find sequence that affects both alleles! 
b. Repair template is 100 bp region centered on cut site in gene 
i. Order two 60 nt oligos with 20 bp overlap around cut site, extend using PCR 
ii. Mutate PAM site and add unique restriction site to confirm transformation 
iii. Add stop codon for knockout 
iv. May be necessary to try more than one guide sequence/repair template 
combination to mutagenize a given gene 
3. Prepare plates 
4. Transform competent bacteria to make more plasmid 
5. Prepare large culture of transformed cells and miniprep 
a. Use QIAprep Spin Miniprep Kit. 
6. Clone guides 
a. Cut pV1393 with BsmBI 
i. Prepare heat block at 55° C 
ii. Digest 2 μg plasmid DNA 
1. 2 μg DNA 
2. 5 μl 10x NEB3.1 
3. 1 μl BsmBI 
4. Add water to 50 μl 
iii. Incubate in heat block for 20 min 
iv. Cool to RT and spin down 
v. Add 1 μl CIP 
vi. Incubate at 37° C for 1 hour 
vii. Purify using QIAquick Gel Column. 
1. Start with isopropanol step. 
2. Elute in 30 μl buffer EB. 
3. Nanodrop to get concentration. 
b. Phosphorylate and anneal sgRNA oligos 
i. Add to a PCR tube: 
1. 0.5 μl 100 μM guide oligo top strand 
2. 0.5 μl 100 μM guide oligo bottom strand 
3. 5 μl 10x T4 Ligase Buffer 
4. 1μl T4 polynucleotide kinase 
5. 43 μl water 
ii. Incubate in a thermocycler 
1. 37° C for 30 min 
50 
 
2. 95° C for 5 min 
3. Cool to 16° C at slowest ramp rate available 
c. Ligate annealed guide oligos into plasmid 
i. Add to a PCR tube: 
1. 1μl 10x T4 ligase buffer 
2. 0.5 μl ligase 
3. 0.5 μl annealed oligos (include negative control with no oligos) 
4. 20-40 ng vector 
5. Add water to 10 μl 
ii. Incubate in thermocycler 
1. 16° C for 30 min 
2. 65° C for 10 min 
3. Cool to 25° C 
d. Transform 5μl to chemically competent DH5 alpha E. coli 
e. Select on 50 μg/ml Nat + 200 μg/ml Amp LB agar plates 
f. Identify correct clones by sequencing 3-4 colonies. (If tandem insertion a problem, 
reduce amount of annealed oligos added to ligation reaction) 
7. Prepare repair template 
a. PCR repair template oligos 
i. 4 x 50 μl reactions, pooled 
ii. Purify using QIAquick Gel extraction column (no gel) 
iii. Elute in 50 μl EB 
iv. Nanodrop 
8. Transform Candida 
a. Linearize plasmid by KpnI and SacI double digest 
b. Use lithium acetate or hybrid lithium acetate/electroporation to make Candida 
competent 
c. Use minimal plasmid and lots of repair template 
i. 1-2μg of linearized plasmid with 6+μg of repair 
ii. Try varying repair template amount while holding plasmid constant if needed 
iii. Include no repair template control 
d. Include pV1081 + repair template as control for mutagenesis efficiency 
i. Positive control to knockout ADE2 gene 
9. Verify transformants 
a. Select on 200 μg/ml Nat plates 
i. Try 400 μg/ml if needed 
ii. Include a no DNA control 
b. Streak for singles. 
c. Use PCR to amplify flanking region and digest PCR product, then run on gel (we 
added EcoRI cut site to repair templates) 
 
